GEHC as reported
GE HealthCare reported $21.0B of revenue over the trailing twelve months, +6.0% on the year before. 10 reported series are charted on this page, each one as filed.
$21.0B
Revenue, trailing twelve months · to Q1 2026 · +6.0% against the twelve months before
- Net Income
- $1.91B
Net Income · −13% year on year · trailing twelve months to Q1 2026
- Op Margin
- 13%
Op Margin · trailing twelve months to Q1 2026
- EPS
- $4.18
EPS · −12% year on year · trailing twelve months to Q1 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $21.0B | +6.0% | Q1 2026 |
| Net Income | $1.91B | −13% | Q1 2026 |
| EPS | $4.18 | −12% | Q1 2026 |
| Gross Margin | 39% | n/a | Q1 2026 |
| Op Margin | 13% | n/a | Q1 2026 |
| Net Margin | 9.1% | n/a | Q1 2026 |
| ROE | 21% | n/a | Q1 2026 |
| ROA | 5.8% | n/a | Q1 2026 |
| ROIC | 12% | n/a | Q1 2026 |
| P/E | 17.5 | n/a | today |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
GE HealthCare (GEHC) - Revenue & ProfitRevenue & ProfitGE HealthCare (GEHC)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com
Medical Devices
Ranks #5 of 35 by Smart Score